Demant AS Financials
| WILYY Stock | USD 18.86 0.03 0.16% |
Demant |
Understanding current and past Demant AS Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Demant AS's financial statements are interrelated, with each one affecting the others. For example, an increase in Demant AS's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Demant AS's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Demant AS ADR. Check Demant AS's Beneish M Score to see the likelihood of Demant AS's management manipulating its earnings.
Demant AS Stock Summary
Demant AS competes with Bone Biologics, BICO Group, and Tenon Medical. Demant AS, a hearing healthcare and audio technology company, develops, manufactures, and sells products and equipment to enhance peoples hearing in Europe, North America, the Pacific, Asia, and internationally. Demant AS was founded in 1904 and is headquartered in Smrum, Denmark. Demant As is traded on OTC Exchange in the United States.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | US24803R1095 |
| Business Address | Kongebakken 9, Smrum, |
| Sector | Healthcare |
| Industry | Medical Devices |
| Benchmark | Dow Jones Industrial |
| Website | www.demant.com |
| Phone | 45 39 17 73 00 |
| Currency | USD - US Dollar |
Demant AS Key Financial Ratios
Demant AS's financial ratios allow both analysts and investors to convert raw data from Demant AS's financial statements into concise, actionable information that can be used to evaluate the performance of Demant AS over time and compare it to other companies across industries.| Return On Equity | 0.28 | |||
| Return On Asset | 0.071 | |||
| Beta | 0.93 | |||
| Z Score | 0.6 |
Demant Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Demant AS's current stock value. Our valuation model uses many indicators to compare Demant AS value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Demant AS competition to find correlations between indicators driving Demant AS's intrinsic value. More Info.Demant AS ADR is rated first in return on equity category among its peers. It is rated first in return on asset category among its peers reporting about 0.26 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Demant AS ADR is roughly 3.88 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Demant AS by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Demant AS's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Demant AS ADR Systematic Risk
Demant AS's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Demant AS volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on Demant AS ADR correlated with the market. If Beta is less than 0 Demant AS generally moves in the opposite direction as compared to the market. If Demant AS Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Demant AS ADR is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Demant AS is generally in the same direction as the market. If Beta > 1 Demant AS moves generally in the same direction as, but more than the movement of the benchmark.
Demant AS November 24, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Demant AS help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Demant AS ADR. We use our internally-developed statistical techniques to arrive at the intrinsic value of Demant AS ADR based on widely used predictive technical indicators. In general, we focus on analyzing Demant Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Demant AS's daily price indicators and compare them against related drivers.
| Information Ratio | (0.24) | |||
| Maximum Drawdown | 7.99 | |||
| Value At Risk | (1.92) |
Additional Tools for Demant Pink Sheet Analysis
When running Demant AS's price analysis, check to measure Demant AS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Demant AS is operating at the current time. Most of Demant AS's value examination focuses on studying past and present price action to predict the probability of Demant AS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Demant AS's price. Additionally, you may evaluate how the addition of Demant AS to your portfolios can decrease your overall portfolio volatility.